BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19034996)

  • 1. Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder.
    Kummer A; Teixeira A
    Australas Psychiatry; 2008 Dec; 16(6):458-9. PubMed ID: 19034996
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylphenidate-induced acute orofacial and extremity dyskinesia.
    Yilmaz AE; Donmez A; Orun E; Tas T; Isik B; Sonmez FM
    J Child Neurol; 2013 Jun; 28(6):781-3. PubMed ID: 22791547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
    Jaworowski S; Benarroch F; Gross-Tsur V
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conclusions inconsistent with results with amphetamines and divalproex.
    Kruszewski SP; Paczynski R
    Am J Psychiatry; 2005 Nov; 162(11):2197; author reply 2197-8. PubMed ID: 16263875
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic and pharmacological variances of bipolar disorder versus attention-deficit/hyperactivity disorder.
    Lysne DH; Peterson T; Erickson K; Uriell M
    Am J Psychiatry; 2006 Dec; 163(12):2196; author reply 2196. PubMed ID: 17151181
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit hyperactivity disorder erroneously diagnosed and treated as bipolar disorder.
    Atmaca M; Ozler S; Topuz M; Goldstein S
    J Atten Disord; 2009 Sep; 13(2):197-8. PubMed ID: 19380515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.
    Levy F
    Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820
    [No Abstract]   [Full Text] [Related]  

  • 11. Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
    Hoekstra PJ; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2016 Apr; 25(4):339-40. PubMed ID: 27021055
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of a case of comorbid bipolar disorder and attention-deficit/hyperactivity disorder.
    Schaller JL; Behar D
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):235-6. PubMed ID: 9608417
    [No Abstract]   [Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder: part III.
    Ryan-Krause P
    J Pediatr Health Care; 2011; 25(1):50-6. PubMed ID: 21147408
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse response to methylphenidate in combination with valproic acid.
    Gara L; Roberts W
    J Child Adolesc Psychopharmacol; 2000; 10(1):39-43. PubMed ID: 10755581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children: A viewpoint by Raul R. Silva.
    Silva RR
    Drugs; 2006; 66(8):1127-8; discussion 1128. PubMed ID: 16789798
    [No Abstract]   [Full Text] [Related]  

  • 18. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
    [No Abstract]   [Full Text] [Related]  

  • 19. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Zarinara AR; Mohammadi MR; Hazrati N; Tabrizi M; Rezazadeh SA; Rezaie F; Akhondzadeh S
    Hum Psychopharmacol; 2010 Nov; 25(7-8):530-5. PubMed ID: 20860068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotempla XR-ODT--another long-acting methylphenidate for ADHD.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):183-185. PubMed ID: 29125594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.